Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N-(3-iodophenyl)-3-oxododecanamide
ID: ALA5268907
Max Phase: Preclinical
Molecular Formula: C18H26INO2
Molecular Weight: 415.31
Associated Items:
ID: ALA5268907
Max Phase: Preclinical
Molecular Formula: C18H26INO2
Molecular Weight: 415.31
Associated Items:
Canonical SMILES: CCCCCCCCCC(=O)CC(=O)Nc1cccc(I)c1
Standard InChI: InChI=1S/C18H26INO2/c1-2-3-4-5-6-7-8-12-17(21)14-18(22)20-16-11-9-10-15(19)13-16/h9-11,13H,2-8,12,14H2,1H3,(H,20,22)
Standard InChI Key: UHJWWGHDYQWNHG-UHFFFAOYSA-N
Molfile:
RDKit 2D 22 22 0 0 0 0 0 0 0 0999 V2000 -2.1446 0.4146 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.1446 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4302 -0.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7158 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7158 0.4146 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.0013 -0.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7130 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4274 -0.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1419 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8563 -0.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5708 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2852 -0.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9997 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7141 -0.8227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8591 -0.8227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.5736 -0.4103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2834 -0.8219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9996 -0.4140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7141 -0.8264 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0 -4.9996 0.4142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2852 0.8264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5736 0.4146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 2 3 1 0 3 4 1 0 4 5 2 0 4 6 1 0 6 7 1 0 7 8 1 0 8 9 1 0 9 10 1 0 10 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 15 2 1 0 16 15 1 0 17 16 1 0 18 17 2 0 18 19 1 0 20 18 1 0 21 20 2 0 22 21 1 0 16 22 2 0 M END
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 415.31 | Molecular Weight (Monoisotopic): 415.1008 | AlogP: 5.33 | #Rotatable Bonds: 11 |
Polar Surface Area: 46.17 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.51 | CX Basic pKa: ┄ | CX LogP: 6.17 | CX LogD: 6.17 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.30 | Np Likeness Score: -0.67 |
1. Ampomah-Wireko M, Luo C, Cao Y, Wang H, Nininahazwe L, Wu C.. (2021) Chemical probe of AHL modulators on quorum sensing in Gram-Negative Bacteria and as antiproliferative agents: A review., 226 [PMID:34626877] [10.1016/j.ejmech.2021.113864] |
Source(1):